News › Clinical Practice, Industry News, Patient Care

Refine USA’s Rejuvapen NXT Microneedling System Earns FDA Clearance

April 16, 2020

Refine USA has been granted a class 2 medical clearance from the FDA for its medical grade microneedling device, Rejuvapen NXT. This recent clearance has expanded its intended use to facial wrinkles.
The Rejuvapen NXT has passed multiple electrical and safety tests for biocompatibility, including testing for irritation, cytotoxicity and sensitization, ensuring none of the materials used are harmful to the patient. These tests include design verification and validation testing. The product is also certified according to ISO/IEC Guide 17067 and in accordance with ANSI/AAMI ES60601.
Click here to learn more about the Rejuvapen NXT >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available